The company has not filed an annual or quarterly report since its Q3 FY2021 10-Q, filed Oct 28, 2021. Its latest SEC filing is a 4 from Mar 14, 2024.
10-Q for Q3 FY2021, filed Oct 28, 2021
The sections below describe the company as of the FY2020 annual report.
Provides clinical development and laboratory services to pharmaceutical, biotechnology, medical-device and government organizations.
10-K for FY2020, filed Feb 26, 2021
Customers pay PPD for clinical development and laboratory services; PPD earns contract revenue as it performs the work and is paid for services rendered, on projects lasting several months to many years.
10-K for FY2020, filed Feb 26, 2021We are a leading provider of drug development services to the biopharmaceutical industry, focused on helping our customers bring their…View ↗
Our backlog represents anticipated direct revenue for work not yet completed or performed (i) under signed contracts, letters of intent…View ↗
In the event a customer terminates a contract, we are generally entitled to be paid for services rendered through the termination date and…View ↗
$4.7B
10-K for FY2020, filed Feb 26, 2021
$4.7B ↗
Customers include pharmaceutical, biotechnology, medical-device and government organizations, as well as academic and nonprofit groups. PPD serves them through clinical development and laboratory services.
10-K for FY2020, filed Feb 26, 2021We are a leading provider of drug development services to the biopharmaceutical industry, focused on helping our customers bring their…View ↗
Our leading capabilities are evidenced by the quality, scale and diversity of our customers. Over the past five years, we have provided…View ↗
The Company is managed through two reportable segments, Clinical Development Services and Laboratory Services. The Company determines…View ↗
Yes. It kept 3 cents of every revenue dollar as net income in .
10-K for FY2020, filed Feb 26, 2021
10-Q for Q3 FY2021, filed Oct 28, 2021
$167.1MView ↗
8-K, filed Dec 8, 2021
The information contained in the Introductory Note of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. As…View ↗
Grew.
Revenue grew 25% in 2 years, from $3.7B in to $4.7B in , about 12% a year.
10-K for FY2020, filed Feb 26, 2021
Loading...
